|
|
 |
|
Viewing report
|
|
|
|
New Cancer Therapeutics: An Analysis Of Current And Emerging Markets
Business Insights, Nov 2002, Pages: 252
In 2001, for the fourth year in a row, the Centers for Disease Control reported a decline in the death rate from cancer, with the most notable decreases in the death rates for breast cancer, prostate cancer, lung cancer, colon cancer and leukemia. This is due in no small part to improved treatments, including more effective prescription drugs. While the death rate from cancer is declining, the number of actual deaths is increasing because of an increasing population and longer life expectancy. The new management report New Cancer Therapeutics: An analysis of current and emerging markets, provides detailed analyses of current drugs and developing technologies to predict future market dynamics. The report also assesses the ability of the pharmaceutical sector to meet the significant unmet need that exists in oncology. The expert analysis of trends and forecasts in this report will help you to identify the areas from which you may the yield greatest returns on your R&D investments - saving you time and money.
Customers who bought this item also bought
Cancer Therapeutics Markets
Cancer Therapeutics - Market Insight and R&D Pipeline Analysis
Cancer Drug Discoveries: What the Future Holds: Prostate Cancer Chapter
Pipeline Insight: Breast Cancer - Recent Approvals Increase Pressure On Pipeline Candidates
The Cancer Clock
Biomarker Technology Platforms for Cancer Diagnoses and Therapies
Drug Delivery in Cancer - Technologies, Markets and Companies
U.S. Breast Cancer Therapeutics Markets
The Cancer Market Outlook to 2012
US Cancer Pain Report
Cancer Therapies - Global Strategic Business Report
Cancer Therapeutics Markets
|
|
|
|
